Short Interest in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Increases By 20.4%
MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 2,830,000 shares, a growth of 20.4% from the August 15th total of 2,350,000 shares. Based on an average trading volume of 1,010,000 shares, the short-interest ratio is currently 2.8 days. Approximately 2.8% of the shares of the stock are sold short. Approximately 2.8% of the shares of the stock are sold short. Based on an average trading volume of 1,010,000 shares, the short-interest ratio is currently 2.8 days.
NASDAQ:REGN
